Advancements in peptide and oligonucleotide synthesis via precision chemistry are transforming therapeutic development by ...
Delpacibart etedesiran led mostly to mild to moderate adverse events in a phase I/II trial of myotonic dystrophy type 1, but two serious events occurred. The antibody-oligonucleotide conjugate reduced ...
REDWOOD CITY, Calif., Jan. 7, 2026 /PRNewswire/ -- Codexis, Inc. (CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing and Axolabs, part of LGC Group, ...
RNA-based medicines are transforming the way we treat disease—offering targeted, precision therapies for conditions ranging from rare genetic disorders to widespread chronic illnesses like diabetes, ...
In today’s competitive biotechnology landscape, control and speed define success for companies and core labs producing synthetic genes. Yet many gene synthesis teams still rely on outsourced oligo ...
Therapeutic oligonucleotides (ONs) offer promising treatments for conditions beyond what traditional therapies can target. As a new class of molecules, they demand precise characterization in both ...
The enzymatic DNA synthesis market is on the cusp of extraordinary expansion. Forecasts indicate that the market will grow from USD 371 million in 2025 to nearly USD 3,938.9 million by 2035, marking ...
Cost-effective oligo system design schematic. Each synthetic oligo consists of two oligos (oligo-A and oligo-B), one forward primer (Primer-A), and two reverse primers (Primer-B and Primer-C). (A) ...
Forbes contributors publish independent expert analyses and insights. David Jagneaux is a writer and analyst, covering MMOs and retro games. I’ve got a code to check it out for myself this weekend, so ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results